Skip to main content
Premium Trial:

Request an Annual Quote

Agendia Gets ISO Accreditation for Microarray-Based Breast Cancer Diagnostic

NEW YORK, Sept. 5 (GenomeWeb News) - Agendia, a Dutch firm that specializes in gene-expression services, said today that it has been granted ISO 17025 accreditation for its MammaPrint service, which assesses the risk of metastasis in breast cancer patients.

 

According to the company, it is the first to be granted this accreditation for a microarray-based diagnostic test.

 

Agendia said that the accreditation is granted for four years, but that the Dutch Accreditation Council will perform yearly inspections of the Agendia laboratory facilities in order to confirm that the company meets the ISO requirements.

 

The Scan

mRNA-Based Vaccine on the Way in China

China may soon have its own mRNA-based vaccine, according to Nature News.

Arranged Killing, Fraud Alleged by Prosecutors

The Wall Street Journal reports that prosecutors allege that the co-founder of a biotech arranged to have a business associate who threatened to expose him as a fraud killed.

Whirlwind Decade of CRISPR

The New York Times looks back at the 10 years since the University of California, Berkeley's Jennifer Doudna and her colleagues published their CRISPR paper.

PNAS Papers on Blue Cone Monochromacy Structural Variants, HIV-1 Mutant, T-ALL

In PNAS this week: structural variants linked to blue cone monochromacy, HIV-1 variants affecting the matrix protein p17, and more.